Blogging Report Study Technical Review 
Startup Professionals Musings
MARCH 19, 2022
In my experience, the good news is that everyone is becoming more and more comfortable with relationships via the new media and technology. Maximize online referrals and positive service reviews. I still find too many service organizations that ignore or discount online reviews and satisfaction surveys.
Both Sides of the Table
APRIL 13, 2011
Brad on blogging. How did you start blogging? “My My initial desire to blog came from something that’s always been my approach to investing – I’m a nerd and I love to play with the technology and part of my approach has really been to understand things both at a user level and at a reasonably deep tentacle level.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Xconomy
OCTOBER 7, 2016
. —Alnylam Pharmaceuticals (NASDAQ: ALNY ) of Cambridge, MA, said that it would shelve its drug revusiran after 18 patients died in a Phase 3 study to treat the rare disease transthyretin amyloidosis. —The 2016 Nobel Prize for Physiology or Medicine went to Yoshinori Ohsumi of the Tokyo Institute of Technology.
Both Sides of the Table
OCTOBER 10, 2011
The remainder of this article will deal with this decision but it comes down to the different economics of DVD rentals due to “ the first sale doctrine ” which gives Netflix a complete library of films and the fact that the first-sale doctrine doesn’t apply to digital downloads. A blog post! No, probably not.
Xconomy
AUGUST 19, 2016
The CRISPR news this week doesn’t need a metaphor; the drama that MIT Technology Review reported can stand alone. Everyone is waiting until 2017, when huge studies of the drugs’ ability to prevent heart attacks and strokes start to provide data. Be our guest and try it.). Time for the gold-medal roundup.
Xconomy
NOVEMBER 11, 2016
—Xconomy rounded up some post-election thoughts from several local tech and life science leaders , which included a mix of outrage, resiliency, hope, rationalizing, grandstanding, and some calls for calm and reason. The Nitto drug is in a Phase 1b study. Bagger is helping run the transition. CRISPR DEVELOPMENTS. 6 at the U.S.
Xconomy
SEPTEMBER 2, 2016
As the San Diego Union Tribune reported in 2013, Tsien (pictured) was also unafraid to shine the spotlight on what he considered suspect scientific approaches, even when espoused by legends like DNA co-discoverer James Watson.
Expert insights. Personalized for you.
121 
Let's personalize your content